Related Experiment Videos
Phase II evaluation of vindesine in patients with advanced colorectal carcinoma
Cancer Treatment Reports
|November 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomized trial of the electronic Lung Cancer Symptom Scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer.
Current oncology (Toronto, Ont.)·2020
Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases.
Cardiovascular and interventional radiology·2018
Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Trends in the sex ratio of cannabis use, harms and perceptions among youth in Ontario, Canada, 1999 to 2023.
Addiction (Abingdon, England)·2026
Effectiveness of colchicine preparation switching in pediatric colchicine-resistant familial Mediterranean fever: a real-world study.
European journal of pediatrics·2026
AOH1996, an Inhibitor of PCNA, Sensitises Breast Cancer Cells to Cytotoxic Chemotherapy.
Breast cancer (Dove Medical Press)·2026